Phoenix Children's Hospital announced the establishment of the $50 million Ronald A. Matricaria Institute of Molecular Medicine to develop targeted drug therapies for children with cancer and other diseases.
The institute is supported by a collaboration between Phoenix Children's, The University of Arizona College of Medicine-Phoenix and the Translational Genomics Research Institute.
The institute's goal is to use molecular medicine to develop individualized drugs for patients based on their genetic makeup. The team at the institute will focus on pediatric cancers first, and later expand to other pediatric diseases.
Moody's: 100 Statistics on Children's Hospital Medians
Children's Hospitals and Clinics of Minnesota Opens New ED
The institute is supported by a collaboration between Phoenix Children's, The University of Arizona College of Medicine-Phoenix and the Translational Genomics Research Institute.
The institute's goal is to use molecular medicine to develop individualized drugs for patients based on their genetic makeup. The team at the institute will focus on pediatric cancers first, and later expand to other pediatric diseases.
More Articles on Hospitals for Children:
6 Considerations Unique to Children's Hospitals in the Drive to Greater Healthcare ValueMoody's: 100 Statistics on Children's Hospital Medians
Children's Hospitals and Clinics of Minnesota Opens New ED